Got a new idea?   |   PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
 


 

15% increase in sales for Gedeon Richter in Czech Republic in H1 2010


2010-08-11

In the first six months of 2010, the sales of Gedeon Richter, the prominent Hungarian drug manufacturer, in the Czech Republic, increased in value by 15% (turnover in H1 2009 was €9.7m), to €11.2m, mainly because of the good sales results of the company’s range of oral contraceptives and the anti-cholesterol drug Larus.
The company has launched several new products on the Czech pharmaceutical market in H1 2010: the (CNS) narcotic analgesic Lunaldin (fentanyl), the gynaecological IUD, Goldlily (Cu+Au) and the cholesterol-lowering rosuvastatin, which contains a product bearing the Mertenil brand name.
The consolidated group sales of Gedeon Richter were worth HUF 137.2bn (€504.5m) in the six months to June 2010, a 2% increase (9.1% in euro terms) in comparison with the equivalent period of 2009.

Browse and search in our archive »


subscribe to PMR RSS NEWS channelsSubscribe to PMR RSS NEWS channels »




PMR publications >> Pharma



Online access:





Central Europe Pharma Online [EN]

1 year subscription to internet service providing market news and analytical articles


Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access



description leaflet buy now add to basket request more info




Newsletters:





Central Europe Pharma News [EN]

12-month subscription (26 issues of biweekly news)


Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file



description sample issue buy now add to basket request more info


 
About us         Contact us         Privacy Policy
Copyright © 2012 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.